Despite the increased evidence of the important role of matrix metalloproteinases(MMP-9 and MMP‐2) in the pathophysiology of hypertension, the profile of thesemolecules in resistant hypertension (RHTN) remains unknown. Here, MMP9 is linked to Hypertension resistant to conventional therapy.